Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.Genes & Development|October 8, 2011
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsHua Jing, Julia Kase, Jan R Dörr, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2013
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphomaMatthias Pfeifer, Michael Grau, Dido Lenze, et al.Cell Reports|October 24, 2019
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor CellsTorben Gehring, Tabea Erdmann, Marco Rahm, et al.Cancer Discovery|September 26, 2014
Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferationKristina Heinig, Marcel Gätjen, Michael Grau, et al.Leukemia|August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trialCiara L Freeman, Prasath Pararajalingam, Ling Jin, et al.Translational Oncology|August 21, 2018
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue SarcomaTorsten Kessler, Ariane Baumeier, Caroline Brand, et al.Blood|June 9, 2023
BRD4 inhibition sensitizes diffuse large B-cell lymphoma cells to ferroptosisAnja Schmitt, Melanie Grimm, Nina Kreienkamp, et al.Blood|July 23, 2013
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCLHendrik Nogai, Sören-Sebastian Wenzel, Stephan Hailfinger, et al.Pageof 5